1. Home
  2. NTHI vs HRZN Comparison

NTHI vs HRZN Comparison

Compare NTHI & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • HRZN
  • Stock Information
  • Founded
  • NTHI 2008
  • HRZN 2008
  • Country
  • NTHI United States
  • HRZN United States
  • Employees
  • NTHI N/A
  • HRZN N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • HRZN Finance/Investors Services
  • Sector
  • NTHI Health Care
  • HRZN Finance
  • Exchange
  • NTHI Nasdaq
  • HRZN Nasdaq
  • Market Cap
  • NTHI 211.9M
  • HRZN 275.7M
  • IPO Year
  • NTHI N/A
  • HRZN 2010
  • Fundamental
  • Price
  • NTHI $9.80
  • HRZN $6.48
  • Analyst Decision
  • NTHI
  • HRZN Hold
  • Analyst Count
  • NTHI 0
  • HRZN 4
  • Target Price
  • NTHI N/A
  • HRZN $7.38
  • AVG Volume (30 Days)
  • NTHI 42.0K
  • HRZN 750.5K
  • Earning Date
  • NTHI 11-19-2025
  • HRZN 10-28-2025
  • Dividend Yield
  • NTHI N/A
  • HRZN 20.79%
  • EPS Growth
  • NTHI N/A
  • HRZN N/A
  • EPS
  • NTHI N/A
  • HRZN N/A
  • Revenue
  • NTHI $59,990.00
  • HRZN $98,899,000.00
  • Revenue This Year
  • NTHI N/A
  • HRZN N/A
  • Revenue Next Year
  • NTHI N/A
  • HRZN $9.61
  • P/E Ratio
  • NTHI N/A
  • HRZN N/A
  • Revenue Growth
  • NTHI N/A
  • HRZN N/A
  • 52 Week Low
  • NTHI $3.20
  • HRZN $5.71
  • 52 Week High
  • NTHI $25.00
  • HRZN $9.99
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • HRZN 58.76
  • Support Level
  • NTHI N/A
  • HRZN $5.81
  • Resistance Level
  • NTHI N/A
  • HRZN $6.71
  • Average True Range (ATR)
  • NTHI 0.00
  • HRZN 0.16
  • MACD
  • NTHI 0.00
  • HRZN 0.11
  • Stochastic Oscillator
  • NTHI 0.00
  • HRZN 77.05

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

About HRZN Horizon Technology Finance Corporation

Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.

Share on Social Networks: